Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Thistle

What does the research say about Thistle?

6 health outcomes synthesised

Thistle (silymarin) has been studied for 6 health outcomes, primarily related to liver function and metabolic markers. The strongest evidence supports its role in reducing aspartate aminotransferase (AST) levels, based on 10 studies with moderate evidence strength, where a commonly effective dose was 420 mg/day in clinical populations with liver stress. Research also shows moderate evidence for benefits on alanine aminotransferase (ALT), alkaline phosphatase, and LDL cholesterol, though effects vary by dose and population.

Strongest evidence: Thistle shows moderate evidence for reducing liver enzymes and improving lipid profiles. For aspartate aminotransferase (AST), 6 of 10 studies reported beneficial effects (moderate evidence) with doses around 420 mg/day, primarily in clinical populations with liver conditions. Similarly, for alanine aminotransferase (ALT), 4 of 6 studies were beneficial (moderate evidence). Alkaline phosphatase (ALP) reductions were seen in all 4 studies (moderate evidence) at 140–420 mg/day. LDL cholesterol reductions were reported in 3 of 4 studies (moderate evidence), though effect sizes were small.

Mixed or weaker evidence: Evidence for triglycerides and gamma-glutamyl transferase (GGT) is lower in strength. For triglycerides, 3 of 4 studies showed benefit, but the largest meta-analysis (n=2283) found a non-significant effect (low evidence). For GGT, 2 of 3 studies were beneficial, but a meta-analysis with 2,069 participants showed a neutral effect (low evidence). These outcomes require more research.

Effective dose patterns: Across multiple outcomes, the most commonly studied silymarin dose was 420 mg/day (for AST, ALT, ALP), with a range of 140–420 mg/day. For triglycerides, a dose of 200 mg three times daily (600 mg/day) was used. Doses are typically reported for standardized silymarin extracts, not crude thistle.

Population insights: The strongest effects are seen in clinical populations with liver stress, such as nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease, drug-induced liver injury, and metabolic dysfunction-associated steatotic liver disease (MASLD). Benefits in healthy adults without liver stress are less clear, and generalizability is limited.

Notable caveats: Publication bias is a concern—null results may be underrepresented. Many studies did not specify the form of thistle used, and effect sizes varied widely. Long-term efficacy and safety beyond 6–24 weeks are not well established. Evidence is predominantly from standardized silymarin; results may not generalize to all thistle products.

Frequently asked

  • What is Thistle good for according to research?
    Research shows thistle (silymarin) may help reduce liver enzymes (AST, ALT, ALP) and improve lipid profiles (LDL, triglycerides) in people with liver conditions. Evidence is strongest for reducing AST levels (10 studies, moderate evidence) and ALT (6 studies, moderate evidence). Benefits are most consistent in clinical populations with liver stress, such as NAFLD or alcoholic liver disease.
  • What dose of Thistle is typically used in studies?
    The most common dose studied is 420 mg/day of standardized silymarin, taken orally. For some outcomes like alkaline phosphatase, doses ranged from 140–420 mg/day. Triglyceride studies used 200 mg three times daily (600 mg/day). Doses are based on clinical trials lasting 6–24 weeks.
  • Who benefits most from Thistle?
    Clinical populations with liver conditions—such as metabolic dysfunction-associated steatotic liver disease, nonalcoholic fatty liver disease, alcoholic liver disease, or drug-induced liver injury—show the most consistent benefits. Evidence in healthy adults without liver stress is limited, and effects may not extend to them.
  • Are there caveats or limitations in the research on Thistle?
    Yes. Publication bias is a potential issue—null results may be less likely to be published. Many studies did not specify the form of thistle used, and effect sizes varied widely. Evidence is mostly from short-term studies (6–24 weeks), so long-term safety is unclear. Most research uses standardized silymarin, not crude thistle products.
  • Does Thistle help reduce triglycerides?
    Evidence is mixed. Three of four studies reported beneficial effects, but the largest meta-analysis (n=2283) found a non-significant effect. The overall evidence strength is low, so more research is needed to confirm a triglyceride-lowering effect.
  • How long do studies typically last?
    Study durations vary by outcome. For AST and ALP, median study duration was about 9 weeks (63 days). For ALT and GGT, median durations were around 15 weeks (104 days). LDL studies lasted up to 24 weeks (168 days). Longer-term effects are not well studied.

Safety profile

15 studies reporting safety data1 increased-risk finding1 serious adverse event

In clinical data, thistle (silymarin) has been associated with a slightly increased rate of adverse effects overall (RR 1.11–3.54) in one study. Across 2 additional studies, no significant difference was observed versus control for serious adverse events (Peto OR 1.55, 95% CI 0.26–9.28) and non-serious adverse events (RR 1.29, 95% CI 0.88–1.89). Most of the 19 unquantified tolerability reports describe thistle as well tolerated, with mild gastrointestinal effects (e.g., nausea, diarrhea, bloating) noted in some studies and no serious adverse events attributed to the supplement.

Caveats: Evidence is largely from short-term studies; long-term safety is not established. Most studies were not primarily designed to assess safety, so rare adverse events may not have been detected.

Most-studied combinations with Thistle

most supplement research is combination research
Also studied with:Turmeric (4), Resveratrol (2), Red Grape (2), Berberine (3), Vitamin E (3), Turmeric (2), green tea (2)

  • Hyperdrive 4.0

    By ALR Industries

    5 (2 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    		Out
    iHerb
    $32.15
    		In
    Vitacost
    $-
    		Out
    Vitamin Shoppe
    $-
    		Out
Back to top